Mara Fumagalli

Dr. Mara Fumagalli

Università degli Studi di Milano, Milan, Lombardy, Italy
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2019 in Frontiers in Pediatrics
Verified
Journal Article
Open access
Chiara MameliChiara Mameli
Chiara Mameli
ICIlaria Cocchi
Ilaria Cocchi
MFMara Fumagalli
Mara Fumagalli
GZGianvincenzo Zuccotti
Gianvincenzo Zuccotti
Influenza vaccine is considered the most effective way to prevent influenza. Nonetheless, every year vaccine coverage is lower than recommended in the pediatric population. Many factors are supposed to contribute to this phenomenon such as the uncertainty about the indication for vaccination, and the suboptimal vaccine-effectiveness in pediatric age, especially in the youngest children. In this review we discuss the effectiveness, indications, and limits of influenza vaccination in the pediatric population based on the most recent evidences.

28 January 2021 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
CCCarla Carnovale
Carla Carnovale
MGMichele Gringeri
Michele Gringeri
VBVera Battini
Vera Battini
GMGiulia Mosini
Giulia Mosini
EIElena Invernizzi
Elena Invernizzi
VFValentina Fabiano
Valentina Fabiano

3 May 2022 in Children
Verified
Journal Article
Open access
PDF file
Valeria RubinacciValeria Rubinacci
Valeria Rubinacci
MFMara Fumagalli
Mara Fumagalli
Giulia MeravigliaGiulia Meraviglia
Giulia Meraviglia
LGLaura Gianolio
Laura Gianolio
ASAnna Sala
Anna Sala
VGVania Giacomet
Vania Giacomet
Congenital cytomegalovirus infection (cCMV) is the most common congenital viral infection, with a consistent rate of morbidity, mortality, and long-term sequelae, especially in the case of late diagnosis. Nevertheless, a universal screening for CMV is not currently recommended, and global awareness about this infection, as well as accurate and shared indications on follow-up and treatment, are still lacking. We reviewed data about 59 suspect cCMV cases who referred to our center from 2014 to 2021. We report 41 cases of confirmed cCMV diagnosed at birth, with clinical or radiological abnormalities in 36.6% of them. Other five patients received a late diagnosis and all presented neurological impairment. Twelve patients received therapy with Valganciclovir within the first month of life, with favorable outcome in nine cases. Therapy after the first month of life was attempted in four patients, with improvement in one case. The overall awareness about cCMV infection was 32.6%. Considering our population, maternal serological screening followed by targeted testing of neonates could be an effective strategy. Some aspects of cCMV infection management should be further investigated, such as indication of treatment after the first month of life or in asymptomatic patients. Awareness about the infection should be improved to implement preventive strategies.

1 April 2021 in Int. Journal of Clinical Pharmacology and Therapeutics
Verified
Journal Article
Closed access
FBFrancesco Bergamaschi
Francesco Bergamaschi
MFMara Fumagalli
Mara Fumagalli
SMSavina Mannarino
Savina Mannarino
PCPatrizia Carlucci
Patrizia Carlucci
SRSonia Radice
Sonia Radice
VFValentina Fabiano
Valentina Fabiano
Objective: We describe a case of severe hypoglycemia in a 14-month-old child as a suspected adverse drug reaction (ADR) to nadolol, and we performed an analysis of the FDA Adverse Event Reporting System (FAERS) database. Although previous reports have identified the risk of severe hypoglycemia in children during treatment with beta-blockers, little is known about hypoglycemia as an ADR in infants treated with nadolol. Moreover, the pharmacodynamic and pharmacokinetic profiles of nadolol in children aged less than 1 year old are still not fully known. Materials and methods: We extracted all ADR reports involving nadolol from the FAERS database; in order to reduce the risk of bias, we only considered cases that exclusively reported nadolol as the suspect drug. We then selected cases of hypoglycemia in the pediatric population and conducted a manual deduplication. Results: Upon FAERS database analysis, a total of 2,674 suspected ADR reports to nadolol were found. Of these, 1,950 (73%) were solely attributed to nadolol, and 63 of them were hypoglycemic events. A total of 47 reports included the relevant pediatric age (74.6%). After deduplication, we identified 25 cases (mean age: 3.65 years old); all of these reports were categorized as serious, and hospitalization was required in 15 cases. Conclusion: Hypoglycemia is a reported life-threatening ADR associated with nadolol, especially in infants, in whom this drug should be used with caution.

28 April 2021 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
LGLaura Gianolio
Laura Gianolio
MFMara Fumagalli
Mara Fumagalli
VMValeria Manfredini
Valeria Manfredini
SMSavina Mannarino
Savina Mannarino
VGVania Giacomet
Vania Giacomet
Gianvincenzo ZuccottiGianvincenzo Zuccotti
Gianvincenzo Zuccotti
Background: While other viral infections occurring in early pregnancy are known to be associated with fetal cardiac malformations, little is known about CMV and its causative role. Only a few case repots have been described reporting a correlation between congenital CMV infection and cardiac defects. Case-report: We report the case of a 7-day-old neonate who was referred to our Pediatric Infectivology Department for maternal cytomegalovirus (CMV) seroconversion during the first trimester of pregnancy and confirmed congenital infection. At first evaluation, the baby presented with a cardiac murmur and signs of acute heart failure, along with jaundice and hypotonia. At cardiac ultrasound, a perimembranous doubly-committed ventricular septal defect and a reduced aortic isthmus diameter were revealed. Conclusion: Despite further large-scale prospective studies are needed to confirm or rule out this association, CMV DNA urine detection might be worth to be considered as part of the diagnostic process in neonates with isolated heart defects.